67
Views
1
CrossRef citations to date
0
Altmetric
Original Research

The radial augmentation index in children with Kawasaki disease without acute coronary artery lesions during the convalescent period

, , , , , & show all
Pages 701-709 | Published online: 12 Jun 2019

References

  • Newburger JW. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American heart association. Circulation. 2004;110(17):2747–2771. doi:10.1161/01.CIR.0000145143.19711.7815505111
  • Shigeru Amano, Hazama F, Hamashima Y. Pathology of Kawasaki disease. Jpn Circ J. 1979;43(7):633–643.
  • Kliegman RM, Bonita S, St. Geme JW III, Behrman RE. Nelson Textbook of Pediatrics. 19th ed. Philadelphia, Pa, USA: Elsevier; 2011.
  • Senzaki H, Masutani S, Kobayashi J, et al. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation. 2001;104(8):860–863.11514369
  • Senzaki H. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child. 2006;91(10):847–851. doi:10.1136/adc.2005.08743716990356
  • Takahashi K, Oharaseki T, Yokouchi Y, Hiruta N, Naoe S. Kawasaki disease as a systemic vasculitis in childhood. Ann Vasc Dis. 2010;3(3):173–181. doi:10.3400/avd.sasvp0100323555407
  • Masuda H, Shozawa T, Naoe S, Tanaka N. The intercostal artery in Kawasaki disease. A pathologic study of 17 autopsy cases. Arch Pathol Lab Med. 1986;110(12):1136–1142.3778140
  • Gupta-Malhotra M, Gruber D, Abraham SS, et al. Atherosclerosis in survivors of Kawasaki disease. J Pediatr. 2009;155(4):572–577. doi:10.1016/j.jpeds.2009.04.05419595365
  • McCrindle BW, McIntyre S, Kim C, Lin T, Adeli K. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis? J Pediatr. 2007;151(3):244–248, 248 e241. doi:10.1016/j.jpeds.2007.03.05617719931
  • Kadono T, Sugiyama H, Hoshiai M, et al. Endothelial function evaluated by flow-mediated dilatation in pediatric vascular disease. Pediatr Cardiol. 2005;26(4):385–390. doi:10.1007/s00246-004-0755-915633046
  • Newburger JW, Burns JC, Beiser AS, Loscalzo J. Altered lipid profile after Kawasaki syndrome. Circulation. 1991;84(2):625–631.1860206
  • Fukunaga H, Kishiro M, Akimoto K, Ohtsuka Y, Nagata S, Shimizu T. Imbalance of peroxisome proliferator-activated receptor gamma and adiponectin predisposes Kawasaki disease patients to developing atherosclerosis. Pediatr Int. 2010;52(5):795–800. doi:10.1111/j.1442-200X.2010.03160.x20487372
  • Oguri M, Nakamura T, Tamanuki K, et al. Subclinical arterial stiffness in young children after Kawasaki disease. Cardiol Young. 2014;24(1):87–94. doi:10.1017/S104795111200230223388098
  • Murakami T, Takeda A, Takei K, et al. Aortic pressure wave reflection in children. Hypertens Res. 2010;33(3):225–228. doi:10.1038/hr.2009.21820057485
  • Hidvegi EV, Illyes M, Molnar FT, Cziraki A. Influence of body height on aortic systolic pressure augmentation and wave reflection in childhood. J Hum Hypertens. 2015;29(8):495–501. doi:10.1038/jhh.2014.11825500901
  • Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3). doi:10.1542/peds.2017-0685.
  • Tobayama H, Takahashi K, Fukunaga H, et al. Analysis of arterial function in adults with a history of Kawasaki disease. J Cardiol. 2013;61(5):330–335. doi:10.1016/j.jjcc.2012.12.00723499175
  • Pinto FF, Laranjo S, Parames F, Freitas I, Mota-Carmo M. Long-term evaluation of endothelial function in Kawasaki disease patients. Cardiol Young. 2013;23(4):517–522. doi:10.1017/S104795111200135723040585
  • Mori Y, Katayama H, Kishi K, Ozaki N, Shimizu T, Tamai H. Persistent high fever for more than 10 days during acute phase is a risk factor for endothelial dysfunction in children with a history of Kawasaki disease. J Cardiol. 2016;68(1):71–75. doi:10.1016/j.jjcc.2015.08.00826381328
  • Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149(2):237–240. doi:10.1016/j.jpeds.2006.03.05016887442
  • Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606–2612. doi:10.1161/CIRCULATIONAHA.105.59286516735679
  • London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38(3):434–438.11566918
  • Safar ME, Blacher J, Pannier B, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39(3):735–738.11897754
  • Urbina EM, Kimball TR, Khoury PR, Daniels SR, Dolan LM. Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens. 2010;28(8):1692–1698. doi:10.1097/HJH.0b013e32833a613220647860
  • Urbina EM, Khoury PR, McCoy C, Daniels SR, Kimball TR, Dolan LM. Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens (Greenwich). 2011;13(5):332–342. doi:10.1111/j.1751-7176.2011.00471.x21545394
  • Urbina EM, Gao Z, Khoury PR, Martin LJ, Dolan LM. Insulin resistance and arterial stiffness in healthy adolescents and young adults. Diabetologia. 2012;55(3):625–631. doi:10.1007/s00125-011-2412-122193511
  • Urbina EM, Khoury PR, McCoy CE, Dolan LM, Daniels SR, Kimball TR. Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults. Pediatrics. 2013;131(4):e1082–e1090. doi:10.1542/peds.2012-172623460684
  • Covic A, Mardare N, Gusbeth-Tatomir P, et al. Increased arterial stiffness in children on haemodialysis. Nephrol Dial Transplant. 2006;21(3):729–735. doi:10.1093/ndt/gfi19616221688